Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Clinical trial NCT05483543 · UNKNOWN

Trial details

NCT number: NCT05483543
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Limited Stage Small Cell Lung Cancer

Start date: 2022-06-20
Primary completion: 2024-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.